We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+21.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$770M
AUM Growth
+$68.8M
Cap. Flow
+$130M
Cap. Flow %
16.87%
Top 10 Hldgs %
19.85%
Holding
481
New
73
Increased
256
Reduced
119
Closed
26

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$7.21M
2
AAPL icon
Apple
AAPL
+$6.33M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$5.14M
4
MSFT icon
Microsoft
MSFT
+$5M
5
META icon
Meta Platforms (Facebook)
META
+$4.68M

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.84%
2 Technology 9.26%
3 Healthcare 4.68%
4 Consumer Discretionary 3.53%
5 Financials 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$898B
$31.5M 4.09%
59,662
-4,406
-7% -$2.6M
IUSB icon
2
iShares Core Universal USD Bond ETF
IUSB
$43.6B
$19.4M 2.52%
426,686
+34,655
+9% +$1.58M
USEP icon
3
Innovator US Equity Ultra Buffer ETF September
USEP
$147M
$18.5M 2.4%
554,660
+32,759
+6% +$1.16M
AAPL icon
4
Apple
AAPL
$4.67T
$15.9M 2.06%
80,572
+27,316
+51% +$6.33M
MSFT icon
5
Microsoft
MSFT
$3.81T
$13.5M 1.75%
36,610
+12,254
+50% +$5M
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$11.6M 1.5%
22,008
+726
+3% +$427K
IBIT icon
7
iShares Bitcoin Trust
IBIT
$58.6B
$11.1M 1.45%
230,923
+52,212
+29% +$2.76M
NVDA icon
8
NVIDIA
NVDA
$5.25T
$10.8M 1.4%
106,279
-643
-0.6% -$81.5K
QUAL icon
9
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
$10.7M 1.39%
66,272
+7,609
+13% +$1.36M
QQQ icon
10
Invesco QQQ Trust
QQQ
$489B
$9.91M 1.29%
22,325
+4,856
+28% +$2.47M
CGGR icon
11
Capital Group Growth ETF
CGGR
$25.2B
$9.8M 1.27%
301,671
+96,720
+47% +$3.62M
TLT icon
12
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
$9.71M 1.26%
110,905
-4,034
-4% -$359K
DYNF icon
13
BlackRock US Equity Factor Rotation ETF
DYNF
$41.2B
$9.55M 1.24%
207,950
+10,981
+6% +$564K
IVW icon
14
iShares S&P 500 Growth ETF
IVW
$76.8B
$9.53M 1.24%
107,698
+6,747
+7% +$680K
IONS icon
15
Ionis Pharmaceuticals
IONS
$10.1B
$9.34M 1.21%
328,904
+157,092
+91% +$5.14M
JPST icon
16
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
$9.27M 1.2%
183,519
-17,266
-9% -$872K
BIL icon
17
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$9.13M 1.19%
99,683
+9,646
+11% +$883K
UDEC
18
Innovator US Equity Ultra Buffer ETF December
UDEC
$247M
$9.01M 1.17%
268,941
+12,414
+5% +$437K
IVE icon
19
iShares S&P 500 Value ETF
IVE
$50.2B
$8.84M 1.15%
49,840
+14,803
+42% +$2.86M
GLD icon
20
SPDR Gold Trust
GLD
$149B
$8.61M 1.12%
28,140
+1,092
+4% +$289K
LTPZ icon
21
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$811M
$8.59M 1.11%
166,455
+17,192
+12% +$920K
EFV icon
22
iShares MSCI EAFE Value ETF
EFV
$31.6B
$7.34M 0.95%
125,286
-15,903
-11% -$900K
BALT icon
23
Innovator Defined Wealth Shield ETF
BALT
$2.82B
$7.21M 0.94%
232,792
+14,338
+7% +$453K
AMZN icon
24
Amazon
AMZN
$2.87T
$6.92M 0.9%
40,107
+7,122
+22% +$1.55M
CGDV icon
25
Capital Group Dividend Value ETF
CGDV
$38.8B
$6.77M 0.88%
202,074
+43,616
+28% +$1.58M

Similar funds

Sovran Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Sovran Advisors held 481 positions worth $770M, up 9.8% from $702M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Sovran Advisors deployed $130M of net new capital in Q1 2025, opening 73 new positions and adding to 256 existing holdings. Its largest new stake was Novo Nordisk: 36,559 shares worth $2.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was PIMCO Dynamic Income Fund, an estimated $2.67M trimmed.

  • Sovran Advisors's largest Q1 2025 buy was Novo Nordisk: 36,559 shares worth $2.12M.
  • Sovran Advisors added most to Qualcomm in Q1 2025, an estimated $7.21M increase.
  • Sovran Advisors's biggest Q1 2025 reduction was PIMCO Dynamic Income Fund, cutting an estimated $2.67M.
  • Sovran Advisors fully exited Celldex Therapeutics in Q1 2025, selling an estimated $2.6M.
  • Sovran Advisors's ten largest holdings make up 20% of its $770M portfolio in Q1 2025.
  • Sovran Advisors opened 73 new positions and closed 26 in Q1 2025.
  • Sovran Advisors's portfolio value rose 9.8% quarter-over-quarter to $770M.

Based on Sovran Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.